Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.17-0.06 (-1.86%)
At close: 4:00 PM EDT
People also watch:
ARQLEXELCLDXRIGLARIA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.25
Prev Close3.23
Bid3.12 x 800
Ask3.19 x 500
Day's Range3.10 - 3.32
52wk Range2.38 - 6.04
1y Target EstN/A
Market Cap459.72M
P/E Ratio (ttm)-4.88
Beta1.25
Volume1,174,661
Avg Vol (3m)2,138,609
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Array BioPharma, Inc. : August 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Array BioPharma, Inc. Here are 5 ETF’s with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016
    Capital Cube3 days ago

    Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016

    Categories: Yahoo Finance Get free summary analysis Array BioPharma, Inc. reports financial results for the year ended June 30, 2016. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Albany Molecular Research, Inc., Astrazeneca PLC Sponsored ADR, Onconova Therapeutics Inc., Eli Lilly and Company, Cascadian Therapeutics Inc. and Novartis ... Read more (Read more...)

  • PR Newswire6 days ago

    Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress

    BOULDER, Colo., Aug. 19, 2016 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that results from a Phase 2 study of ARRY-797 will be presented at the 2016 European Society of Cardiology ...